| these data suggest that IDH2 may be a tumor suppressor in that its loss may promote malignant progression of gastric cancer via NF-kappaB-dependent increases in MMP7 activity. | gastric, |
| neomorphic IDH2 mutations can be oncogenic in mesenchymal cells | None |
| These data demonstrate the proto-oncogenic role of mutant IDH2. | None |